Background: Choline is an important nutrient either obtained from a variety of foods or synthesized endogenously, and it
Introduction
Choline is an important nutrient obtained from a variety of foods (1) . In European populations the main sources of dietary choline are meat, milk, grain, egg, and fish (2) . According to North American health authorities, an adequate intake of choline is 425 and 550 mg/d for women and men, respectively (3) . However, studies from the United States (4, 5) and Europe (2) suggest that intake of choline may be inadequate.
The total choline content in foods includes free choline in addition to choline species, such as glycerophosphocholine, phosphocholine, phosphatidylcholine, and sphingomyelin (6) . Choline may also be formed by de novo biosynthesis via methylation of phosphatidylethanolamine, catalyzed by phosphatidylethanolamine N-methyltransferase (7). Choline is required for the synthesis of acetylcholine and phospholipids, which are necessary components of lipoproteins and cellular membranes (1, 7) . In the mitochondria, choline is oxidized to betaine, which serves as an intracellular osmolyte in addition to being a methyl donor in the remethylation of homocysteine catalyzed by betaine-homocysteine methyltransferase (BHMT) 12 (1, 7). Conversion of choline to betaine is the only endogenous pathway of betaine synthesis, although betaine may also be obtained from the diet. Foods with the highest content of betaine are whole grain, wheat bran, wheat germ, spinach, and shrimp (6, 8) .
Studies of health-related effects of dietary choline in community-dwelling participants have shown that low and high intakes may be associated with adverse health effects. High choline intake has been related to increased risk of colorectal adenomas (9) . High intake of choline and betaine have also been related to a favorable body composition in humans (10) . Low choline intake has been associated with hepatic fat accumulation, liver and muscle damage (11) , and impaired cognitive function (12) . In animal studies, diets low in choline may adversely affect bone health (13, 14) . Our group previously reported that low concentrations of plasma free choline (15) and dimethylglycine (16) , the immediate betaine catabolite, were associated with low bone mineral density (BMD) in humans, whereas no relations were observed with plasma betaine (15) . However, it is unclear whether intake of choline and betaine is reflected in their systemic concentrations and if such intakes influence bone health in humans (17) (18) (19) (20) .
The aims of this study were to examine associations of dietary choline and choline species as well as betaine with BMD and to examine correlations between intake of total choline and betaine with plasma concentrations of free choline and betaine in a cross-sectional study of community-dwelling middle-aged and older adults.
Methods
Study population. Participants in this cross-sectional study were from the Hordaland Health Study (HUSK) in Western Norway and examined in 1998-2000. The HUSK was a collaboration between the University of Bergen, the Norwegian Institute of Public Health, and local health services. The 9187 invited participants were born in 1925-1927 (older cohort) or 1950-1951 (middle-aged cohort) and had previously participated in the Hordaland Homocysteine Study in 1992-1993 (21) .
A total of 7074 participants (77% of those invited) met for examinations and completed self-administered questionnaires about health status, lifestyle factors, and use of medications. Of the 7074 participants attending the health examinations, we obtained femoral neck BMD measurements from 5378 subjects, and of these, 4762 completed an FFQ. The FFQ was handed out on the day of the health examination, filled out at home, and returned by mail to the HUSK project center. Participants with a very low [<3000 kJ or 717 kcal for women (n = 57); <3300 kJ or 788 kcal for men (n = 13)] or a very high [>15,000 kJ or 3583 kcal for women (n = 21); >17,500 kJ or 4180 kcal for men (n = 39)] estimated daily energy intake were excluded. This left 4632 subjects, of whom 65.5% attended the health examination (1600 women and 1024 men aged 46-49 y, and 1049 women and 959 men aged 71-74 y).
The study was approved by the Regional Committee for Medical and Health Research Ethics. Each participant signed an informed consent form.
BMD measurements. BMD was measured by DXA on a stationary fan beam densitometer (Expert-XL; Lunar Company Inc.) operated by 4 skilled technicians (22) . The left hip was scanned except when there was a history of hip fracture or insertion of a hip-joint prosthesis. Femoral neck BMD was used in the analyses, and having low-femoral neck BMD was defined as being in the lowest quintile in each age and sex group.
Assessment of dietary intake. Information on dietary intake was obtained by using a validated 169-item FFQ (23) , which assessed habitual diet during the past year and included frequency alternatives, the number of portions, and portion sizes. The FFQ was previously validated against multiple, weighed dietary records for 14 d in elderly men and women and against serum carotenoids and FA composition in adipose tissue and serum (23) (24) (25) . The frequency of consumption was specified per day, week, or month. Information on the use of supplements was obtained from the FFQ and included in the calculations. A database and a software system (KBS software, version 3.2; University of Oslo) developed at the Department of Nutrition, University of Oslo, were used to calculate nutrient intake. Choline and betaine intakes were estimated according to the USDA choline database (26) . Total choline was calculated as the sum of free choline and choline from glycerophosphocholine, phosphocholine, phosphatidylcholine, and sphingomyelin.
Analytic procedures. Nonfasting blood samples were collected in evacuated tubes containing EDTA, chilled, and centrifuged (1000 3 g; 10 min; 4°C) within 1-3 h. EDTA-plasma was stored at 280°C. Plasma free choline, betaine, and cotinine were measured by LC-MS/MS 6-8 y after collection without any thaw-freeze cycles (27, 28) . CVs were 3.8-7.6% for plasma free choline and 5-11.7% for plasma betaine (27) . Within-day and between-day CVs were determined on sample replicates on controls (29) . Plasma cotinine concentrations $85 nmol/L were used to identify current smokers (30) . High-sensitive C-reactive protein (hs-CRP) was determined by a novel immunoassay based on matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (31) . The analyses were performed at the BEVITAL laboratory, Bergen, Norway.
Other measurements. Detailed information about measurements of weight, height, BMI (in kg/m 2 ), physical activity, and hormone replacement therapy has been presented previously (15) .
Statistical analysis. Categorical variables are expressed as numbers (percentages) and continuous variables as medians (IQRs). All dietary nutrients were energy-adjusted by using the residual method (32) . Trends across tertiles of dietary total choline and betaine were tested by logistic and linear regression for categorical and continuous variables, respectively. The analyses were adjusted for sex and age group. Sex was adjusted for age group. One-factor ANOVA with BonferroniÕs correction was used to compare choline intake between sex and age group. We explored potential nonlinear relations between dietary intake of total choline and BMD in all participants in generalized additive models adjusting for sex and age group.
ORs for being in the lowest quintile of femoral neck BMD according to sex-and age-specific tertiles of dietary choline and betaine were estimated in logistic regression analyses. We explored potential interactions between sex and dietary choline intake in relation to BMD in the 2 age groups by introducing a product term between tertiles of the dietary choline variables (continuous) and sex (dichotomous) in the binary logistic regression analyses. The logistic regression models were adjusted for age group and sex as well as potential confounding factors, including BMI, nicotine exposure, physical activity, hs-CRP, and dietary intakes of vitamin D and calcium. Further adjustment for dietary protein intake as well as estrogen supplementation (in women) did not alter the risk estimates and were left out of the multivariate model (data not shown). Unadjusted analyses were also performed, and the results were similar but somewhat weaker than in the adjusted analyses; thus, we present results from the adjusted models.
The correlations between dietary and plasma concentrations of choline and betaine were assessed by using SpearmanÕs bivariate rank order correlation (r).
Two-tailed P values <0.05 were considered statistically significant. The analyses were performed by using SPSS for windows (IBM SPSS Statistics 22) and software package mgcv for R, version 3.1.2 (The R Foundation for Statistical Computing).
Results
Study population. Characteristics of participants according to tertiles of energy-adjusted dietary intake of total choline and betaine are presented in Table 1 .
Median energy-adjusted total choline intakes in middle-aged women and men were 255 mg/d (IQR: 63 mg/d) and 259 mg/d (IQR: 74 mg/d), respectively, and in elderly women and men 265 mg/d (IQR: 61 mg/d) and 258 mg/d (IQR: 61 mg/d), respectively. Age-and sex-specific analyses showed that elderly women had higher intakes than middle-aged women (P = 0.001) and middleaged men (P = 0.015). Dietary intake of total choline was positively correlated with intakes of meat, fish, eggs, milk, fiber, calcium, and protein but negatively associated with the intakes of carbohydrates and fat (Table 1) . Dietary choline was also positively correlated with nicotine exposure and BMI and inversely associated with hs-CRP.
Dietary betaine was positively associated with dietary fiber and carbohydrates as well as plasma betaine but negatively associated with intakes of meat, fish, eggs, milk, vitamin D, calcium, and total fat as well as with any nicotine exposure and BMI (Table 1) .
Three hundred forty-two (21.4%) middle-aged and 128 (12.2%) elderly women reported current use of hormone-replacement therapy (P < 0.001), and there were no significant differences between use and nonuse across tertiles of choline or betaine intake. Dietary choline and betaine in relation to BMD. The positive relation between intake of total choline and BMD in all subjects combined is shown in Figure 1 (b: 0.05, P = 0.001). Furthermore, participants in the lowest compared with highest tertile of dietary total choline, free choline, glycerophosphocholine, phosphocholine, phosphatidylcholine, and sphingomyelin were more prone to have a low BMD ( Table 2 ). In analyses stratified by age group and sex, similar results were found among middleaged men for whom the (nominal) strongest associations were observed for intakes of free choline (OR: 1.83; 95% CI: 1.24, 2.69; P = 0.002), glycerophosphocholine (OR: 2.13; 95% CI: 1.43, 3.16; P < 0.001), and phosphocholine (OR: 1.81; 95% CI: 1.23, 2.66; P = 0.003). In elderly women similar associations were seen for the intakes of total choline, free choline, phosphatidylcholine, and sphingomyelin (Table 2 ). Significant interactions between sex and dietary intake of total choline (P-interaction = 0.001), phosphatidylcholine (P-interaction < 0.001), and sphingomyelin (P-interaction = 0.046) were found in relation to risk of low BMD among the elderly and for glycerophosphocholine (P-interaction = 0.046) among the middle-aged age group. No significant associations were observed between dietary betaine and BMD (Table 2) .
Dietary choline and betaine in relation to plasma free choline and betaine. Intakes of total choline, free choline, glycerophosphocholine, phosphocholine, and phosphatidylcholine were weakly positively correlated with plasma free choline in the whole population (r: 0.07, 0.05, 0.07, 0.07, and 0.05, respectively; P < 0.01). In analyses stratified by sex and age group, dietary total choline correlated weakly with plasma concentration of free choline among middle-aged and elderly men (r: 0.08 and 0.06, respectively; P < 0.05) but not among women ( Table 3) .
Overall (r: 0.23, P < 0.001) and in all sex and age groups, dietary betaine was significantly correlated with plasma betaine (Table 3) .
Discussion
Intakes of total free choline, glycerophosphocholine, and phosphocholine were positively associated with BMD in middle-aged men, and intakes of total choline, free choline, phosphatidylcholine, and sphingomyelin were positively associated with BMD in elderly women. No significant associations with BMD were observed for dietary betaine. We observed a weak positive correlation between total choline intake and plasma concentration of free choline and a moderate positive correlation between betaine intake and plasma betaine.
To our knowledge, our study is the first to examine the associations of habitual intake of choline and betaine with BMD in humans. Our current findings support our previous observations suggesting an association of low concentrations of plasma free choline (15) and dimethylglycine (16) with low BMD, whereas no significant relations were observed between plasma betaine and BMD (15) .
We observed weak-to-moderate positive correlations between dietary intake and plasma concentrations of choline and betaine. Plasma free choline seems to be most predictive of BMD because the OR for having low BMD was somewhat stronger for the lowest compared with the highest tertiles of plasma free choline (OR: 2.00; 95% CI: 1.17, 1.66) (15) than for the lowest compared with the highest tertiles of dietary choline (OR: 1.36; 95% CI: 1.14, 1.63) when comparing the whole population. In other studies, the relations between dietary and circulating choline (17, 18) as well as between dietary and systemic betaine concentrations (19) have been divergent. This may be due to differences in doses, study durations, or study cohorts. In addition, de novo choline synthesis may be increased when intake is insufficient (33, 34) thereby weakening potential correlations.
The associations between choline intake and BMD are supported by observations in animal studies because cholinedeficient rats had altered mandibular bone remodeling detected as a marked reduction in osteogenesis (13) and reduced bone formation and increased bone resorption, promoting reduced cancellous and cortical bone mass (14) . Phosphatidylcholine is a ligand for PPARa and PPARg (35, 36) . Activation of PPARa may have a protective role in regulation of bone metabolism (37) , whereas activation of PPARg may lead mesenchymal stem cells to differentiate into adipocytes and not osteoblasts (38) .
Inflammation is associated with low BMD (39) . Our findings of an inverse association between choline intake and plasma C-reactive protein (CRP) are in accordance with previous studies in which a low dietary intake of choline was associated with an increased concentration of the inflammatory markers CRP, IL-6, and TNF-a (40), which are also inversely associated with BMD (41, 42) . CRP was the only inflammatory marker available in our study, and adjusting for CRP did not materially change the association between dietary choline and BMD, suggesting that the relation is not mediated by inflammatory mechanisms alone.
We have previously reported that elevated plasma homocysteine concentrations were related to low BMD in women in the HUSK (22) in agreement with results from a recent study published by others (43) . Choline supplementation (44) and dietary intake (4) may reduce plasma homocysteine concentrations; thus, there may be a connection between effects of choline and homocysteine on BMD in women.
Low choline intake has been associated with metabolic syndrome and nonalcoholic fatty liver disease in animal models (45) . However, in the current cohort high plasma concentrations of free choline and low betaine were related to at UNIVERSITETSBIBLIOTEKET I BERGEN on May 11, 2017 jn.nutrition.org certain components of the metabolic syndrome (46) . The metabolic syndrome (47, 48) and nonalcoholic fatty liver disease (49) have been related to increased risk of low BMD in some studies.
In analyses stratified by sex and age group, we found the highest OR between choline intake and BMD among middleaged men and elderly women. A weak significant association was also found in middle-aged women for total choline and phosphatidylcholine, whereas no significant associations were observed in elderly men. In our earlier observations, the strongest positive association between plasma concentration of free choline and BMD was seen among elderly women (15) . The median daily intake of choline was higher among elderly women than middle-aged men and women. These sex and age differences may be partly explained by transcriptional regulation of human BHMT by estrogen and androgen (50) . Estrogen induces expression of the phosphatidylethanolamine N-methyltransferase gene in premenopausal women, thereby stimulating endogenous choline production (51) . In a clinical study of choline deficiency sequelae, premenopausal women had a higher endogenous production of choline than postmenopausal women did (11) . These findings may explain our results of a weak, significant association between choline intake and BMD among the women in their 40s, considering that the average age at menopause is ;50 y. Unfortunately, we did not have information about menstrual status, although adjusting for use of estrogen supplements did not alter the results. We previously have shown that low plasma dimethylglycine also was associated with low (16) , and although neither dietary nor systemic betaine (15) has been related to BMD, our results may suggest that a low choline intake may reduce flux via BHMT, thereby leading to low dimethylglycine. Because BHMT flux is associated with transcription of apoB, the main protein of VLDL (52) , future studies should evaluate if the association between low choline and low BMD may be mediated by impairment of lipid metabolism. Among middle-aged men, significant associations with BMD were observed for glycerophosphocholine and phosphocholine but not phosphatidylcholine, whereas the opposite was observed in elderly women. This may be due to differences in intakes, bioavailability (6) , or metabolism of choline species, factors that may cause residual confounding. Further studies should explore the effects of different dietary choline species and choline intake from different foods on BMD.
Strengths of our study include the large number of participants recruited from the community and not selected because of specific conditions or diseases, which decreases the risk of reverse causation. We had extensive clinical and biochemical information, and we observed that choline intake was positively correlated with BMI, fat mass, smoking, physical activity, and intakes of vitamin D, calcium, and proteins. A high intake of betaine had the opposite relation regarding BMI, fat mass, smoking, and vitamin D. A low BMI (53), fat mass (54), lack of physical activity (55), smoking (56) , and low intakes of vitamin D, calcium (57) , and protein (58) may be related to low BMD and thus confound our findings between choline intake and BMD. Adjusting for these factors strengthened the associations somewhat, suggesting that additional mechanisms may explain the association between choline intake and BMD.
The current FFQ has not been validated for choline or betaine intake but has been evaluated against a 14-d weighed dietary record, FAs in adipose tissue, and serum carotenoids (23) (24) (25) . Our dietary choline and betaine data were calculated according to a US database (26) because no Norwegian data exist, thus the amount of choline and betaine in some foods may not accurately reflect the content in Norwegian foods. However, the main sources of dietary choline according to the US database are meat, fish, eggs, and milk (4), which are common foods in the Norwegian diet (59) . Notably, intakes of these foods were also positively associated with total choline intake in this study population. The main sources of dietary choline are expected to be very similar in Norway and the United States.
Intakes of choline and betaine in our population were similar to those reported in Norwegian patients with suspected stable coronary heart disease (60) . Moreover, the validity of using an FFQ for the calculation of choline and betaine intakes has been reported by others (4). In agreement with other studies among European (2) and US populations (4, 5), our participants reported choline intakes below current recommendations. Thus, the FFQ used in the current study seemed to provide plausible data on choline and betaine intakes, although misclassification cannot be disregarded.
In conclusion, intake of choline was positively associated with BMD and with plasma free choline among middle-aged and elderly community-dwelling participants. These results should encourage further studies on dietary choline and bone health to elucidate any clinical applicability for dietary intervention.
